, . , . () , , , , , , , , . / , and/or . , , and/or , and/or
It is estimated that 38 million people around the world are infected with the Human Immunodeficiency Virus (HIV), making it a huge worry for the health of people all over the world. It is possible to contract HIV through direct contact with infected blood or other body fluids. The most common ways in which HIV is passed on are through unprotected sexual activity, the sharing of needles, and the transmission of the virus from a mother to her child either during childbirth or while the mother is breastfeeding. Antiretroviral drugs may not be able to prevent the spread of HIV, but they can arrest the progression of the disease and, in some extremely unusual instances, even reverse it.
According to healthline, this is correct. One of the most effective means of preventing the transmission of HIV is through the use of pre-exposure prophylaxis (PrEP). PrEP is a medication regimen that people who do not have HIV use to lower the likelihood that they may become infected with the virus. PrEP is recommended for people who are at a high risk of developing HIV, such as men who engage in sexual activity with other men, people who have multiple s*xual partners, and drug injectors. PrEP is also recommended for people who inject drugs.
The most well-known medication for HIV prevention is called Truvada, and it contains a combination of the antiretroviral drugs tenofovir and emtricitabine. When it was first made available to the public in 2012, the HIV prevention medication Truvada has demonstrated a high level of efficacy. But, there is a possibility that some people won’t be able to afford Truvada, and the possibility that it would have adverse effects will rule them out as candidates.
Even while Truvada is the most well-known medication for PrEP, there are a number of other choices that are equally effective. In these kinds of situations, medications known as post-exposure prophylaxis (PEP) are used. PEP can be used to prevent HIV infection if it is started within 72 hours of being exposed to HIV. Pre-exposure prophylaxis is recommended for everyone who may have been exposed to HIV, healthcare workers who have been pierced by a needle or had unprotected intercourse with an HIV-positive person (PEP).
Medicines that are used in PEP are quite similar to those that are contained in Truvada, and a therapy that lasts for 28 days is typically prescribed. The most popular pre-exposure prophylaxis (PEP) medicine is Truvada, which contains the active components tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC). In spite of this, Raltegravir, one of the other medicines in the PEP category, is also very effective in lowering the risk of HIV transmission.
Even if an individual has already been exposed to HIV, there is still a chance that PEP medication can prevent infection. Postexposure prophylaxis (PEP) medication is at its most efficient when given within the first 72 hours following an exposure, but it can still be useful up to 28 days afterwards. The PEP drug often only causes mild, transient, and barely noticeable adverse effects.
Even while Truvada is the most popular choice for PrEP medication, there are other options, such as PEP medication, that are just as effective. Pre-exposure prophylaxis (PEP) medication is an important choice for those who may have been exposed to HIV and is an essential tool in the fight against the virus. Pre-exposure prophylaxis (PEP) medication is an important choice for those who may have been exposed to HIV. If you are concerned about getting HIV, you should make an appointment with a medical professional as soon as you can in order to get information on pre-exposure prophylaxis (PEP) drugs.
Content created and supplied by: TomWorld (via Opera
News )
